Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-16-012641

Options or other derivatives

  • CFO and EVP acquired 78,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shaff Eric D. · CFO and EVP

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-02-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +78,500 $26.20 2026-01-31 78,500 78,500 D
Loading xslF345X03/doc4.xml…